AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2005
2004 | 2005
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
A 6-MONTH PLACEBO-CONTROLLED STUDY OF VENLAFAXINE XR IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER
|
Encore Presentation | ||
|
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents
|
Work in Progress | ||
|
A Naturalistic, Retrospective Evaluation of Aripiprazole Use in Child and Adolescent Psychiatric Inpatients
|
Work in Progress | ||
|
A Psychoeducation Program that Reduces Metabolic Syndrome Risk Factors in the Severe and Persistently Mentally Ill
|
Original Research | ||
|
A retrospective evaluation of metabolic indices in patients who switched atypical antipsychotic agents
|
Work in Progress | ||
|
Abuse of psychotropic medication in the correctional setting: identification, assessment and harm reduction through education & formulary changes
|
Best Practices | ||
|
ACUTE WEIGHT GAIN WITH COMBINATION DIVALPROEX SODIUM AND OLANZAPINE IN CHILDREN AND ADOLESCENT INPATIENTS AT A UNIVERSITY HOSPITAL
|
Encore Presentation | ||
|
ADAMANTANE DERIVATIVE (MEMANTINE): PHARMACOKINETICS IN HEALTHY AND RENALLY IMPAIRED SUBJECTS
|
Original Research | ||
|
Adherence to American Psychiatric Association Practice Guidelines for the Treatment of Patients with Severe Acute Mania
|
Work in Progress | ||
|
Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia
|
Encore Presentation | ||
|
ADVERSE EVENTS DURING ANTIPSYCHOTIC CLINICAL TRIALS OF ELDERLY PATIENTS WITH DEMENTIA
|
Encore Presentation | ||
|
An assessment of safety, preference, effectiveness, quality of life, and tolerability (SPEQT) in patients with epilepsy switched from immediate-release to extended-release carbamazepine capsules
|
Encore Presentation | ||
|
Analog Classroom Study of Amphetamine Extended Release and Atomoxetine in Youth with ADHD
|
Encore Presentation | ||
|
Analysis of the Efficacy of Venlafaxine vs Placebo in A Subgroup of Patients With Moderate or Severe Major Depression
|
Encore Presentation | ||
|
ANTIDEPRESSANT MEDICATION MANAGEMENT IN DEPRESSION PATIENTS: A ROLE FOR CLINICAL PHARMACISTS
|
Work in Progress | ||
|
Antidepressants and risk of falls
|
Original Research | ||
|
Antipsychotic Polypharmacy: Pharmacoepidemiology and Potential Predictors of Utilization
|
Original Research | ||
|
Antipsychotics and Side Effect Burden: A Prospective Study Comparing Antipsychotic Monotherapy Versus Combination Therapy
|
Work in Progress | ||
|
ARIPIPRAZOLE BIOEQUIVALENCE: ORALLY DISINTEGRATING TABLET COMPARED TO TABLET FORMULATION
|
Encore Presentation | ||
|
Aripiprazole induced seizure in an adolescent
|
Encore Presentation | ||
|
Assessment of Patient Satisfaction with Sustained-release Antidepressant Use in a Family Practice Setting: Pilot Study of Antidepressant Survey
|
Work in Progress | ||
|
ASSOCIATION BETWEEN MEDICATION CHANGES AND FALLS IN GERIATRIC PSYCHIATRY PATIENTS
|
Work in Progress | ||
|
Association of Anxiety Symptoms with Treatment Outcomes Among Outpatients With Major Depression
|
Original Research | ||
|
ATOMOXETINE EFFICACY FOR SEVERE HYPERACTIVE AND INATTENTIVE ADHD SYMPTOMS
|
Encore Presentation | ||
|
ATOMOXETINE’S EFFICACY OVER TIME IN CHILDREN AND ADOLESCENTS WITH ADHD
|
Encore Presentation | ||
|
Atypical Antipsychotic Agents & Risk Factors for Diabetes Mellitus: Comparing Schizophrenic & Bipolar Disorder Patients
|
Encore Presentation | ||
|
CARDIOVASCULAR EFFECTS OF EXTENDED-RELEASE MIXED AMPHETAMINE SALTS IN CHILDREN WITH ADHD
|
Encore Presentation | ||
|
CARDIOVASCULAR EFFECTS OF MIXED AMPHETAMINE SALTS XR IN ADULT ADHD
|
Encore Presentation | ||
|
Centralized Pharmaceutical Care Consultations in a Regional State Psychiatric Facility
|
Best Practices | ||
|
Clinical and Economic Outcomes Associated with the Use of Long Acting Risperidone Injection in a Texas Community Mental Health Clinic
|
Work in Progress | ||
|
CLINICAL RELEVANCE OF DEPRESSIVE SYMPTOM IMPROVEMENT IN BIPOLAR DEPRESSED PATIENTS TREATED WITH OLANZAPINE-FLUOXETINE COMBINATION
|
Encore Presentation | ||
|
CONCERNS OF MENTAL HEALTH CONSERVATORSHIP ATTORNEYS REGARDING PSYCHOTROPIC MEDICATION USE -- IMPLICATIONS FOR PRACTITIONERS
|
Best Practices | ||
|
Continuity of Antipsychotic Pharmacotherapy Among Medicaid Recipients
|
Original Research | ||
|
Delirium in Long-Term Care Residents Predicted by an Anticholinergic Drug Rating Scale and Not Serum Anticholinergic Activity
|
Original Research | ||
|
Development and Implementation of Computerized Staff Training Modules to Teach Psychopharmacology
|
Original Research | ||
|
Development of Aligorithms for Three Main Axis I Disorders ( Schizophrenia, Bipolar Disorder and Major Depression) in a Community Based Mental Health Facility
|
Best Practices | ||
|
Development of Doctor of Pharmacy Industry Advanced Practice Experience
|
Best Practices | ||
|
Double-Blind, Placebo-Controlled Study of Quetiapine in Bipolar Depression
|
Encore Presentation | ||
|
DULOXETINE AT DOSES OF 60 MG QD AND 60 MG BID IS FFECTIVE IN TREATMENT OF DIABETIC NEUROPATHIC PAIN (DNP)
|
Encore Presentation | ||
|
DULOXETINE VS. PLACEBO IN THE TREATMENT OF ELDERLY PATIENTS WITH MDD
|
Encore Presentation | ||
|
Effect of Food on the Bioavailability of Galantamine Extended-Release (ER) Capsule and Pharmacokinetic Comparison of Galantamine ER with Galantamine Immediate-Release (IR) Tablet
|
Original Research | ||
|
EFFECT OF MEMANTINE ON BEHAVIORAL OUTCOMES IN MILD TO SEVERE ALZHEIMER’S DISEASE
|
Original Research | ||
|
EFFICACY AND TOLERABILITY OF DULOXETINE: COMPARISON OF 30 MG QD AND 60 MG QD STARTING DOSES
|
Encore Presentation | ||
|
EFFICACY OF ARIPIPRAZOLE IN SUB-POPULATIONS OF BIPOLAR DISORDER PATIENTS WITH ACUTE MANIA: A POOLED ANALYSIS
|
Encore Presentation | ||
|
ELECTROCARDIOGRAPHIC EVALUATION OF INTRAMUSCULAR ZIPRASIDONE IN CHILDREN AND ADOLESCENTS
|
Original Research | ||
|
ELEVEN YEAR INTERIM RESULTS OF AN INTERNATIONAL OBSERVATIONAL STUDY OF PREGNANCY OUTCOMES FOLLOWING EXPOSURE TO LAMOTRIGINE
|
Encore Presentation | ||
|
Evaluation of an activation syndrome associated with the initiation of aripiprazole in children and adolescent inpatients admitted to a psychiatric unit at a university medical center
|
Work in Progress | ||
|
Evaluation of the Time Course of Reversal of Valproate Mediated Inhibition of Lamotrigine
|
Encore Presentation | ||
|
Evaluation of ziprasidone mesylate guidelines for use at the medical university of south carolina (MUSC)
|
Original Research | ||
|
Extended-Release Carbamazepine for Treatment of Manic and Mixed Symptoms
|
Encore Presentation | ||
|
GENETIC ANALYSIS OF THE RELATIONSHIP BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR AND SCHIZOPHRENIA
|
Work in Progress | ||
|
GLYCEMIC CONTROL OF PSYCHIATRIC PATIENTS ON ATYPICAL ANTIPSYCHOTICS AND HYPOGLYCEMICS: A DRUG UTILIZATION EVALUATION
|
Work in Progress | ||
|
IMMEDIATE SWITCHING OF ANTIDEPRESSANT THERAPY:RESULTS FROM A CLINICAL TRIAL OF DULOXETINE
|
Encore Presentation | ||
|
Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital
|
Best Practices | ||
|
Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital
|
Best Practices | ||
|
Increased Risk of Mortality Associated with Psychotropic Drug Use in VA Patients Admitted for Pneumonia.
|
Original Research | ||
|
Increased Utilization of Ziprasidone Decreased Daily Antipsychotic Costs in an Inpatient Unit
|
Original Research | ||
|
Infection risk among patients receiving long-term clozapine treatment.
|
Work in Progress | ||
|
Insight into Medication Knowledge and Reasons for Nonadherence as Reported by Patients with Mental Illness
|
Original Research | ||
|
Introduction of an Opiate Review Committee into a Restricted Access Health Care System
|
Best Practices | ||
|
LONG-TERM EFFECTS OF ATOMOXETINE ON GROWTH IN CHILDREN WITH ADHD
|
Encore Presentation | ||
|
Long-Term Efficacy and Safety of Galantamine Extended Release for the Treatment of Mild to Moderate Alzheimer’s Disease
|
Original Research | ||
|
MEMANTINE DECREASES THE LEVELS OF ALZHEIMER β-AMYLOID PROTEINS IN RAT PRIMARY CORTICAL NEURONS AND HUMAN NEUROBLASTOMA CELLS
|
Encore Presentation | ||
|
METABOLIC MONITORING WITH ATYPICAL ANTIPSYCHOTICS: IMPACT OF PUBLISHED GUIDELINES
|
Work in Progress | ||
|
Off-label use of Selective Serotonin Reuptake Inhibitors in a Family Medicine Practice
|
Original Research | ||
|
Open-Label Trial of Escitalopram in the Treatment of PTSD
|
Original Research | ||
|
OVERALL TREATMENT EFFECTIVENESS AS MEASURED BY TIME CONTINUING ON ANTIPSYCHOTIC THERAPY
|
Encore Presentation | ||
|
Pharmacoeconomics and Design of Optimal Dosage Regimens
|
Best Practices | ||
|
PRESCRIBING PATTERNS OF ATYPICAL ANTIPSYCHOTICS IN PATIENTS DISCHARGED FROM A UNIVERSITY BASED PSYCHIATRIC HOSPITAL
|
Work in Progress | ||
|
Prevention of Panic Disorder Relapse in Adult Outpatient Responders to Treatment with Venlafaxine XR
|
Encore Presentation | ||
|
QUALITY-OF-LIFE ASSESSMENT IN ATOMOXETINE-TREATED ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
|
Encore Presentation | ||
|
Quetiapine for the Treatment of Agitation in Institutionalized Patients with Dementia: A Randomized, Double-Blind Trial
|
Encore Presentation | ||
|
Rehospitalization Rates during Conditional Release in Mentally Ill Forensic Commitments: A Retrospective Study
|
Work in Progress | ||
|
Relationship Between Sub-therapeutic Dosing of Atypical Antipsychotic Agents and Use of Adjunct Antidepressant and Antianxiety Agents
|
Original Research | ||
|
Retrospective Analysis of Extended-Release Divalproex for Schizophrenia and Mood Related Disorders in an Inpatient Mentally Ill Population
|
Original Research | ||
|
SAFETY AND EFFICACY OF MAS XR IN ADOLESCENTS WITH ADHD
|
Encore Presentation | ||
|
SAFETY AND EFFICACY OF MIXED AMPHETAMINE SALTS EXTENDED RELEASE IN CHILDREN AND ADOLESCENTS WITH OPPOSITIONAL DEFIANT DISORDER (ODD)
|
Encore Presentation | ||
|
Serotonin 5HT2A (-1438G/A and T102C) and G-protein beta subunit (GNB3 C825T) polymorphisms and SSRI-associated sexual dysfunction
|
Work in Progress | ||
|
Switch rate comparison among antidepressant agents
|
Work in Progress | ||
|
Switching form immediate-release to extended-release carbamazepine capsules: safety and tolerability in adolescents with epilepsy
|
Encore Presentation | ||
|
Switching Patients With Alzheimer’s Disease From Galantamine Immediate-Release to Extended-Release Formulation: A Pharmacokinetic Simulation
|
Original Research | ||
|
Symptom profiles of prepubertal children with a diagnosis of ADHD, bipolar disorder, or a depressive disorder
|
Original Research | ||
|
THE EFFECT OF PHARMACEUTICAL CARE INVOLVING REINFORCEMENT OF NON-PHARMACOLOGICAL TREATMENT ON ABSTINENCE IN BUPRENORPHINE TREATED PATIENTS
|
Work in Progress | ||
|
The Effect of Second Generation Antipsychotics on Weight Gain in Children and Adolescents
|
Work in Progress | ||
|
The Prevalence of Co-Morbid Physical Illness in State Hospital Inpatients with Schizophrenia
|
Original Research | ||
|
The use of the adverse event profile for evaluating tolerabilty of carbamazepine therapy given as immediate-release and extended-release formulations
|
Encore Presentation | ||
|
Tolerability of Escitalopram in the Treatment of Social Anxiety Disorder
|
Encore Presentation | ||
|
Treatment of Manic and Mixed Patients with Extended-Release Carbamazepine
|
Encore Presentation | ||
|
UPDATE OF MEMANTINE SAFETY IN SHORT- AND LONG-TERM TREATMENT OF DEMENTIA
|
Original Research | ||
|
Venlafaxine XR and Paroxetine in the Short-Term Treatment of Panic Disorder
|
Encore Presentation |